{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:21:33Z","timestamp":1758759693688,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GeneScience"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40268-025-00513-w","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T07:23:04Z","timestamp":1752304984000},"page":"241-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Bioequivalence Study of Recombinant Human Follicle-Stimulating Hormone Injection Versus Recombinant Human Follitropin For Injection in Healthy Chinese Adult Women"],"prefix":"10.1007","volume":"25","author":[{"given":"Jigang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"513_CR1","first-page":"302","volume":"26","author":"H Lin-Li","year":"2017","unstructured":"Lin-Li H, Guo-ning H, Hai-xiang H, Li-Qing F, Yun F, Huang S. CSRM guideline for the use of ovulation induction drug. J Reprod Med. 2017;26:302\u20137.","journal-title":"J Reprod Med"},{"issue":"4","key":"513_CR2","first-page":"211","volume":"35","author":"JM Qiao","year":"2015","unstructured":"Qiao JM, Liu CH, Ma JY, Li X, Yang S, Zhang Y, La B, Wang X, Zhu X. A consensus of poor ovarian response. Chin J Reprod Contracept. 2015;35(4):211\u201323.","journal-title":"Chin J Reprod Contracept"},{"issue":"4","key":"513_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/17425247.2017.1289174","volume":"14","author":"J Schertz","year":"2017","unstructured":"Schertz J, Worton H. Patient evaluation of the redesigned follitropin alfa pen injector. Expert Opin Drug Deliv. 2017;14(4):473\u201381.","journal-title":"Expert Opin Drug Deliv"},{"key":"513_CR4","first-page":"995","volume-title":"Managing infertility with the follitropin alfa prefilled pen injector\u2013patient considerations","author":"K B\u00fchler","year":"2015","unstructured":"B\u00fchler K. Managing infertility with the follitropin alfa prefilled pen injector\u2013patient considerations. UK: Taylor & Francis; 2015. p. 995\u20131001."},{"issue":"12","key":"513_CR5","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1080\/17425247.2017.1237940","volume":"13","author":"F Jeannerot","year":"2016","unstructured":"Jeannerot F, Cusin A, Schertz J. Dose accuracy of the redesigned follitropin alfa pen injector for infertility treatment. Expert Opin Drug Deliv. 2016;13(12):1661\u20139.","journal-title":"Expert Opin Drug Deliv"},{"key":"513_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S21421","author":"C Abbotts","year":"2011","unstructured":"Abbotts C, Salgado-Braga C, Audibert-Gros C. A redesigned follitropin alfa pen injector for infertility: results of a market research study. Patient Preference Adher. 2011. https:\/\/doi.org\/10.2147\/PPA.S21421.","journal-title":"Patient Preference Adher."},{"issue":"2","key":"513_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/humrep\/deae274","volume":"40","author":"KI Kiose","year":"2025","unstructured":"Kiose KI, Storr A, Kolibianakis EM, Mol BW, Venetis CA. Biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART: a systematic review and meta-analysis. Hum Reprod. 2025;40(2):343\u201359.","journal-title":"Hum Reprod"},{"key":"513_CR8","unstructured":"EMA. Guideline on similar biological medicinal products. https:\/\/www.ema.europa.eu\/en\/similar-biological-medicinal-products-scientific-guideline. Accessed 26 April 2025."},{"key":"513_CR9","volume-title":"LiverTox: clinical and research information on drug-induced liver injury","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: clinical and research information on drug-induced liver injury. USA: National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"issue":"1","key":"513_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1185\/030079904X18027","volume":"21","author":"I Lugan","year":"2005","unstructured":"Lugan I, Febbraro S, Lecuelle H, Papasouliotis O, Ho-Nguyen Q, Buraglio M. Bioequivalence of liquid and freeze-dried recombinant human follicle-stimulating hormone. Curr Med Res Opin. 2005;21(1):121\u20135.","journal-title":"Curr Med Res Opin"},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13318-015-0257-6.pdf","volume":"41","author":"M Wolzt","year":"2016","unstructured":"Wolzt M, et al. Comparison of pharmacokinetic and safety profiles between Bemfola\u00ae and Gonal-f\u00ae after subcutaneous application. Eur J Drug Metab Pharmacokinet. 2016;41:259\u201365. https:\/\/doi.org\/10.1007\/s13318-015-0257-6.pdf.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"513_CR12","volume-title":"Nonparametric statistical methods","author":"M Hollander","year":"2013","unstructured":"Hollander M, Wolfe DA, Chicken E. Nonparametric statistical methods. New York: John Wiley & Sons; 2013."},{"key":"513_CR13","unstructured":"EMA. Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human follicle stimulating hormone (r-hFSH). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-non-clinical-and-clinical-development-similar-biological-medicinal-products-containing-recombinant-human-follicle-stimulating-hormone-r-hfsh_en.pdf. Accessed 28 April 2025."},{"key":"513_CR14","unstructured":"N. M. P. A. (NMPA). Provisions for Drug Registration 2020. http:\/\/english.nmpa.gov.cn\/2022-06\/30\/c_785628_6.htm. Accessed 28 April 2025."},{"key":"513_CR15","unstructured":"N. M. P. A. (NMPA). Requirements for registration classification and application dossiers of biological products 2020. https:\/\/english.nmpa.gov.cn\/2020-06\/30\/c_528660.htm. Accessed 28 April 2025."},{"issue":"4","key":"513_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/wics.1310","volume":"6","author":"SC Chow","year":"2014","unstructured":"Chow SC. Bioavailability and bioequivalence in drug development. Wiley Interdiscip Rev Comput Stat. 2014;6(4):304\u201312. https:\/\/doi.org\/10.1002\/wics.1310.","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"issue":"4","key":"513_CR17","first-page":"258","volume":"51","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, et al. A randomized, single-blind, parallel-controlled and multicentre study: compare the efficacy and safety of domestic and imported human recombinant FSH in WHO group II anovulatory infertility. Zhonghua Fu Chan Ke Za Zhi. 2016;51(4):258\u201363.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"2","key":"513_CR18","first-page":"1387","volume":"41","author":"LX Yang Rui","year":"2021","unstructured":"Yang Rui LX, Zhu Y, Li Y, Yang D, Diao F, Yin P, Li T, Liu A, Li Y, Li L, Wang J, Xiong H, Li R. Clinical application of domestic recombinant human follicle-stimulating hormone in controlled ovarian hyperstimulation with assisted reproductive technology. Chin J Reprod Contracept. 2021;41(2):1387\u201394.","journal-title":"Chin J Reprod Contracept"},{"key":"513_CR19","unstructured":"Changchun L. GeneScience Pharmaceutical Co., Jinfollin\u00ae(Recombinant human follitropin for injection) [package insert]. Changchun, Jilin, China; 2015."},{"key":"513_CR20","unstructured":"EMD-Serono. GONAL-F\u00ae (follitropin alfa for injection). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/020378s045,s067,s075lbl.pdf. Accessed 28 April 2025."},{"key":"513_CR21","unstructured":"Ipsen-Pharma. Diphereline (triptorelin acetate for injection) [package insert]. China; 2017."}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-025-00513-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-025-00513-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-025-00513-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:04:52Z","timestamp":1758744292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-025-00513-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s40268-025-00513-w","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"type":"print","value":"1174-5886"},{"type":"electronic","value":"1179-6901"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"12 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GeneScience sponsored the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Tianhong Luo, Ying Ding, Xiaoyan Zhu, and Weiwei Gao are employees of GeneScience.We have fully considered the conflicts of interest policy, according to the Journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The data supporting this study's findings are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai General Hospital (Date 11 Nov 021\/No.[2021]146).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read, approved the final manuscript, and consented to its publication.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable. The study used only licensed commercial software without any custom code.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors contributed to the study's conception and design. Material preparation, data collection, and analysis were performed by Jigang Zhang, Mingjian Zhang, Wenyuan Xue, Yixin Zha, Shujing Jin, Tianhong Luo, Ying Ding, Xiaoyan Zhu, Weiwei Gao, and Xueying Ding. The first draft of the manuscript was written by Jigang Zhang, and all authors commented on previous versions.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contribution"}}]}}